NEO · NASDAQ · Medical - Diagnostics & Research

NeoGenomics (NEO)

Runs cancer diagnostic laboratories serving community oncologists, pathologists, and pharmaceutical trial sponsors.

$18.71
vs last close−0.18 (−0.95%)